As the founder of StopAfib.org, I have heard from thousands of atrial fibrillation patients who have shared their afib experiences with me. For so many of us, the diagnosis and treatment of afib is confusing and scary. To improve communication between patients and their health-care providers, and ultimately, provide better care, I recently shared with [...]
Atrial Fibrillation Patients Needed for Study of Fish Oil Supplements
We have received word of a study at Vanderbilt University to determine if fish oil supplements decrease afib. Below is the info they sent in case you are interested in participating and are in the Nashville, Tennessee area… Recruiting Patients with Atrial Fibrillation We are recruiting patients with atrial fibrillation to participate in an NIH-sponsored [...]
What Atrial Fibrillation Patients Want Doctors to Know: Bridging the Afib Communications Gap
Mellanie True Hills, founder of StopAfib.org, recently spoke at the Fourth Annual Western Atrial Fibrillation Symposium. Many of her remarks to this medical conference are summarized in an article just published in EP Lab Digest. You may wish to share it with family and friends who need to understand what it’s like to live with [...]
Paid Study for Atrial Fibrillation Patients Who Have Had Cardioversion
watchLAB is hosting a market research study in Los Angeles, Pittsburgh and Seattle with Atrial Fibrillation patients who have experienced both chemical (IV) and electrical cardioversion, preferably in the past 2 years. If you qualify, you will be invited to participate in a one hour interview or a small 1.5-hour group discussion to share your [...]
CHADS2 Scores May Understate Atrial Fibrillation Stroke Risk
New research from Denmark shows that CHADS2 underestimates stroke risk. In the study, atrial fibrillation patients who were at intermediate risk with the CHADS2 scoring system had more than twice the stroke rate of those defined by the enhanced CHA2DS2-VASc tool as being at intermediate risk. While CHADS2 deemed 32.3% of patients to have intermediate [...]
If Catheter Ablation Reduces Alzheimer’s Disease and Stroke Risk Then Keeping Atrial Fibrillation Patients in Sinus Rhythm May Become the Goal
Findings presented at Heart Rhythm 2010 showed that stopping atrial fibrillation—whether through medication, surgery, or in the case of this study, catheter ablation— could potentially prevent the risk of developing Alzheimer’s disease and other dementias and also reduce the risk of stroke and death. Doctors John D. Day, MD, and T. Jared Bunch, MD, at [...]
Urgent Request for UK Atrial Fibrillation Patients to Contact NICE About Dronedarone
The Atrial Fibrillation Association in the UK was shocked by the decision by the National Institute for Health and Clinical Excellence (NICE) to deny atrial fibrillation patients access to dronedarone, a medication that has been approved in the U.S. and Europe. AFA is conducting a campaign to make the voices of atrial fibrillation patients heard. [...]
Action for Stroke Prevention Launches How Can We Avoid a Stroke Crisis? To Expose Risk of a Stroke Crisis in Europe from Atrial Fibrillation
Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead every year. A report, How Can We Avoid a Stroke Crisis?, was launched today in the European Parliament in Brussels by Action for Stroke Prevention, a group of health experts [...]
